Skip to main content



Local Cdiff information for Delaware

Delaware

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Delaware.



Local Cdiff information for Delaware

Delaware

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Delaware.

Providers

Regulation

C. diff Infections

Total Reported Cases: 232
Hospital Onset: 232
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.68
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: Healthcare Associated Infections Disclosure Act (76 Del. Laws, c. 122,
STATUTE >

State Contact

Judy Walrath, Ph.D.
Healthcare-Associated Infections and Influenza Surveillance Coordinator
Delaware Division of Public Health
Jesse Cooper Building
417 Federal Street
Dover, 19901
302-744-4801
EMAIL JUDY WALRATH, PH.D. >

CLINICAL TRIALS

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.